Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of host substrates of SARS-CoV-2 main protease
Ivonne Melano, Yan-Chung Lo, Wen‐Chi Su
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 11

Showing 11 citing articles:

On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 17
Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease
Junwei Zhou, Peng Sun, Yuanqing Wang, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 6
The Main Protease of Middle East Respiratory Syndrome Coronavirus Induces Cleavage of Mitochondrial Antiviral Signaling Protein to Antagonize the Innate Immune Response
Mariska van Huizen, Xavier Martinez Vendrell, Heidi L.M. De Gruyter, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 256-256
Open Access | Times Cited: 5
A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant viruses
Benjamin Van Loy, Eugènia Pujol, Kenichi Kamata, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 2, pp. e1012571-e1012571
Open Access
Determination of SARS-CoV-2 Main Protease (Mpro) Activity Based on Electrooxidation of Tyrosine Residue of a Model Peptide
Tatiana A. Filippova, Rami A. Masamrekh, Tatiana Farafonova, et al.
Biochemistry (Moscow) (2025) Vol. 90, Iss. 1, pp. 120-131
Closed Access
The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes
Dong‐Hwi Kim, Jae‐Hyeong Kim, Min‐Tae Jeon, et al.
Viruses (2025) Vol. 17, Iss. 5, pp. 724-724
Open Access
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1345-1345
Open Access | Times Cited: 3
In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2
Timur Saliev, Shynar Tanabayeva, Neilya Ussebayeva, et al.
Journal Of Advanced Pharmacy Education And Research (2024) Vol. 14, Iss. 3, pp. 1-8
Closed Access | Times Cited: 1
Marine Origin vs. Synthesized Compounds: In Silico Screening for a Potential Drug Against SARS-CoV-2
Amar Osmanović, Mirsada Salihović, Elma Veljović, et al.
Scientia Pharmaceutica (2024) Vol. 93, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and combines a direct antiviral effect with subtle boosting of interferon
Benjamin Van Loy, Eugènia Pujol, Kenichi Kamata, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Differential Kinetics of SARS-CoV-2 Proteases Revealed by a Dual-Color, BRET-based Protease Biosensor, DuProSense
Asma Fatima, Anupriya M. Geethakumari, Shahid Uddin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Page 1

Scroll to top